Analysts expect Lipocine Inc. to report revenue of 150,061.59 for Q3 26, against a range of 137,459.87 to 162,663.31. The most recent reported quarter, Q2 26, came in at 190,100.00, a 15.9% miss against the 226,154.88 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 3.50 M | 93,860.00 | 622,850.00 | 114,570.00 | 1.12 M | 119,400.00 | 190,100.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 137,444.72 | 2.86 M | 369,001.92 | 254,963.76 | 240,976.61 | 116,155.90 | 176,472.38 | 246,701.28 | 162,663.31 | 166,991.91 | 110,676.56 | 107,614.73 | 64,238.62 | 408,015.23 | -76,000.99 | 287,129.35 | ||||||||||
| Low Estimate | 115,091.94 | 2.59 M | 306,644.48 | 233,974.14 | 206,560.97 | 104,725.50 | 165,957.38 | 205,608.48 | 137,459.87 | 147,395.21 | 101,743.44 | 100,741.27 | 53,270.02 | 370,709.63 | -85,514.75 | 240,321.27 | ||||||||||
| Consensus Estimate | 126,268.33 | 2.73 M | 337,823.20 | 244,468.95 | 223,768.79 | 110,440.70 | 171,214.88 | 226,154.88 | 150,061.59 | 157,193.56 | 106,210.00 | 104,178.00 | 58,754.32 | 389,362.43 | -80,757.87 | 263,725.31 |
Analysts expect Lipocine Inc. to report earnings per share of -0.33 for Q3 26, against a range of -0.35 to -0.31. The most recent reported quarter, Q2 26, came in at -0.32, a 25.6% beat against the -0.43 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.44 | 0.33 | -0.35 | -0.41 | -0.59 | -0.42 | -0.54 | -0.32 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.48 | -0.36 | -0.34 | -0.38 | -0.54 | -0.53 | -0.46 | -0.39 | -0.31 | -0.35 | -0.26 | -0.25 | -0.33 | -0.24 | -0.30 | -0.21 | ||||||||||
| Low Estimate | -0.54 | -0.40 | -0.38 | -0.46 | -0.60 | -0.63 | -0.52 | -0.47 | -0.35 | -0.39 | -0.32 | -0.29 | -0.37 | -0.28 | -0.34 | -0.23 | ||||||||||
| Consensus Estimate | -0.51 | -0.38 | -0.36 | -0.42 | -0.57 | -0.58 | -0.49 | -0.43 | -0.33 | -0.37 | -0.29 | -0.27 | -0.35 | -0.26 | -0.32 | -0.22 |
Pull Wall Street consensus for Lipocine Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LPCN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LPCN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LPCN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();